Walking through the boundless landscape of red rocks and limestone cliffs in Texas' Big Bend National Park last March, a volunteer and a park ranger came across a plant they didn't recognize.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...